Munich, Germany

Nicole Rieth



 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Nicole Rieth

Introduction

Nicole Rieth is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of two patents to her name, her work focuses on innovative solutions for autoimmune diseases.

Latest Patents

Nicole's latest patents include groundbreaking inventions related to antibodies directed to Fc gamma receptor IIB and Fc epsilon receptor. The first patent discloses recognition molecules that bind with a first binding domain to the Fc epsilon receptor and with a second binding domain to the Fc gamma receptor IIB. These recognition molecules have potential applications in various therapeutic areas. The second patent provides an anti-Fc-gamma receptor IIB antibody that markedly increases ITIM phosphorylation of FcyRIIB compared to prior art antibodies. This advancement can be utilized for the treatment or prophylaxis of autoimmune diseases.

Career Highlights

Nicole Rieth is currently employed at Suppremol GmbH, where she continues to push the boundaries of scientific research and innovation. Her work has garnered attention in the biotechnology community, and she is recognized for her expertise in antibody development.

Collaborations

Some of her notable coworkers include Anna Carle and Peter Sondermann, who contribute to the collaborative environment at Suppremol GmbH.

Conclusion

Nicole Rieth's contributions to the field of biotechnology through her innovative patents highlight her role as a leading inventor. Her work not only advances scientific knowledge but also holds promise for improving treatments for autoimmune diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…